Afatinib Dimaleate Tablet - Targeted Treatment For Metastatic Non-small Cell Lung Cancer, Fda-approved Egfr Mutation Therapy

Price:

Get Latest Price

In Stock

Product Specifications

Dosage	20,30,40 mg
Formulation	Film-coated tablets
Packaging	Blister packs
Storage	Controlled conditions
Shelf life	24 months
Active ingredient	Afatinib dimaleate
Inactive ingredients	Various excipients
Features	Targeted therapy, Cancer treatment, EGFR inhibitor, Metastatic NSCLC, Improved survival, Reduced tumor growth, Enhanced quality of life

Product Overview

Key Features

Company Details

Business Type

Exporter, Importer, Distributor, Supplier, Trading Company

Employee Count

Establishment

1985

Working Days

Monday To Sunday

Explore Related Categories

Cancer Herbal Medicine

Anti Cancer Injection

More Products From This Seller

Arsenic Trioxide Injection General Medicines

Pemgem Injection - Quality-Assured Pemetrexed Solution | Effective Treatment for Non-Squamous Non-Small Cell Lung Cancer & Malignant Pleural Mesothelioma

Tresivac Vaccine - Lyophilized Powder, 0.5 mL Single-dose Vial for Subcutaneous Use, Refrigerated Storage

Dacogen - Nucleoside Metabolic Inhibitor for Myelodysplastic Syndromes Treatment | Affordable Excellence in MDS Management

Biomab

Geftinat - Targeted Cancer Treatment for Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Previous Chemotherapy Required

Melphalan Tablet - Alkylating Agent for Cancer Treatment | Used for Multiple Myeloma and Ovarian Cancer, Requires Doctor Supervision, Risk of Bone Marrow Suppression

Bortecad For Injection

Pegfilgrastim Injection - Colloidal Solution for Neutrophil Count Recovery | Reduces Infection Risk During Chemotherapy, Enhances Survival After Radiation Exposure